Su Kyung Kim

Evaluating Now I Know mHealth intervention promoting HPV vaccine completion among young women attending federally supported clinics

Abstract Purpose This study evaluated the feasibility, acceptability, usability, and HPV vaccine completion rate of the Now I Know (NIK) mHealth intervention to promote HPV vaccine completion among minority and low-income young women. Methods This quasi-experimental pilot study recruited 35 women aged 18–26 at two federally supported outpatient clinics in a large city in the Northeastern United States. Participants were allocated to two groups: 24 received the NIK intervention plus usual care and 11 received usual care only. After completing a baseline assessment, intervention group participants launched the NIK mobile app, which entailed HPV vaccine education, self-managed vaccine record & reminder, and Q&A features. Follow-up visits were conducted at 2 and 6 months. Feasibility was assessed through screening, recruitment, fidelity, and retention. Acceptability and usability were evaluated via survey and exit interview. The primary outcome—HPV vaccine 3-dose series completion—was analyzed using descriptive statistics. Results This study demonstrated feasibility by reaching the recruitment target (n = 35) and high retention rate (89%). Participants reported the app was acceptable, appreciating reliable information, convenient access, providing a personal touch, and raising awareness. Regarding usability, users found the app easy to navigate, accessible, well organized, and user-friendly. The HPV vaccine completion rate was higher in the intervention group (55%) than in the usual care group (45.5%). Conclusion Findings showed improved vaccination completion among those using the Now I Know mHealth intervention (compared to usual care), acceptability of the intervention, and feasibility of recruiting, retaining, and delivering the intervention to promote HPV vaccine completion among young women in federally subsidized healthcare settings.

The Potential of Human Papillomavirus Self-Collection Testing to Improve Cervical Cancer Screening Among Women Living With HIV

In this short review we summarize two recent studies in which researchers assessed the validity and acceptability of human papillomavirus (HPV) self-collection testing among U.S. women living with HIV. The first study evaluated both the performance and acceptability of the test, and the second study explored the perspectives and needs regarding its potential implications. Clinic-based self-collection HPV testing among women living with HIV demonstrated good sensitivity, moderate specificity, and high acceptability compared to clinician-collected tests. It is imperative for nurses to stay informed about emerging cervical cancer screening test methods and to be prepared for their future implications.

Pilot Randomized Controlled Trial of an Intervention to Promote HPV Uptake Among Young Women Who Attend Subsidized Clinics

To evaluate the preliminary efficacy, acceptability, and feasibility of Step Up to Prevention, a technology-enhanced intervention to promote human papillomavirus (HPV) vaccination uptake among young minority and low-income women. A pilot randomized controlled trial. Two federally supported outpatient clinics in a large city in the northeastern United States. Women who were 18 to 26 years of age (N = 60). We randomized participants into four groups: computer information, in-person tailored, combined, and usual care. We administered computer-assisted self-interview surveys before the intervention (baseline), immediately after the intervention (postintervention), and after their clinic visit (post-clinic visit). We conducted a descriptive analysis of participant characteristics. For preliminary efficacy, we used logistic regression-assessed HPV vaccine initiation uptake rates, and we used descriptive statistics to compare theoretical mediators. We used conventional content analysis to assess participant feedback about intervention acceptability. We assessed feasibility through recruitment and retention rates and our ability to deliver the intervention. We observed significant differences in initial HPV vaccine uptake between the intervention groups and the usual care group. Participant feedback indicated that the intervention was acceptable, empowering, and informative. We met our recruitment target, maintained a high retention rate (98%), and delivered the complete intervention to all participants. We report the preliminary efficacy, acceptability, and feasibility of this intervention to promote HPV vaccine initiation among young women in federally subsided health care settings by advancing favorable views and improving knowledge about HPV vaccination.